Dudediligence.

Tenax Therapeutics, Inc

TENXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.0MSep ’24−$6.3MDec ’24−$10.4MMar ’25−$10.8MJun ’25−$15.8MSep ’25−$15.5MDec ’25−$15.7MMar ’26−$17.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$0.00$0.00
Operating income−$32.7M$11.1M−$8.2M−$19.5M−$56.4M
Net income−$32.5M$11.0M−$7.7M−$17.6M−$52.6M
Operating cash flow−$10.9M−$11.4M−$5.9M−$14.8M−$35.8M
Free cash flow−$10.9M−$11.4Mnone on filenone on filenone on file
Cash$5.6M$2.1M$9.8M$94.9M$97.6M
Shares outstanding1.3M28.6K298.3K3.4M9.3M